Florida-based Trulieve Cannabis Corp.
The catalyst for this high percentage gain was the flurry of acquisitions that the company has made in Florida, totaling more than $500 million over the past year.
The company produces and sells a suite of cannabis products under consumer brands, including Encore, Avexia, MÃV, and Verano.
This week Verano Holdings also did so well in the market, its shares began to spike after hours on Friday, October 5, and by the end of the day, shares of VRNOF closed up 18.43% at $11.32, with an estimated market cap of $1.5 billion.
Also in Illinois, Verano recently completed a renovation and expansion of its Zen Leaf Evanston storefront at 1804 Maple Avenue, which approximately doubled the dispensary’s footprint.
TerrAscend high percentage gain was due to the company’s announcement that it had plans to enter Michigan’s marijuana market after reaching a deal to buy local operator Gage Growth in an all-stock transaction worth $545 million.
is a cannabis company that cultivates, processes, and supplies cannabis products to pharmacies, medical clinics, and cosmetic companies worldwide.
On November 3, 2021, Flora Growth reached a definitive agreement to acquire Carlsbad, California-based Vessel Brand.
With ketamine already a licensed medicine, the phase II a/b results allow Awakn to immediately deliver the KARE treatment in its clinics in the U.K.
In addition, Professor David Nutt, Chief Research Officer of Awakn, and Dr.
It has a pipeline of development programs for radiodermatitis, glioblastoma multiforme, pruritus, rashes, dry skin, and chemotherapy-induced neuropathy.
The entire system is the size and look of a bicycle helmet and could, in the future, be more broadly used for neuroscientific or physiological studies of brain activity during psychedelic use.
Led by a team of esteemed faculty, the program offers psychedelic clinical trial facilitators the foundational training needed to provide skillful and ethical care to participants receiving psychedelic treatment.
Additionally, the US DEA granted Cybin a Schedule I manufacturing license, a federal requirement for investigators who intend to study, produce, analyze or otherwise work with Schedule I controlled substances.
Finally, Cybin will host an in-person and virtual R&D briefing releasing research findings and data on Monday, November 8, 2021, from 8:30 am to 9:30 am E.T.
Nio’s earnings aren’t even out yet, but already shares of the Chinese electric car maker are running downhill.
Palantir, best known as the company whose tech helped locate Osama bin Laden, went public about a year ago and immediately shot higher as the market considered the potential commercial-sector applications for its data analytics tools.
Most Read from BloombergWhy Hong Kong Is Building Apartments the Size of Parking SpacesWhere Did All the Public Bathrooms Go?Do Prisons Deserve a Second Chance?COP26 Protests: Inflatable Cows, Megaphones and a RainbowThe Rising Pacific Forces a Native Village to Move.
If you’re looking for a smart place to put your money to work in November, the following three Dow stocks are screaming buys.
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Mid Cap Growth Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
In this article, we discuss the top 10 stocks to buy according to Ken Heebner’s Capital Growth Management.
The positive trend of rising share prices for 3D printing companies that began with a Desktop Metal press release a week ago and continued through Stratasys’ big earnings beat on Thursday came to a screeching halt today after 3D Systems reported some earnings of its own.
If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Mineral Stocks To Buy Now.
The company’s 10-Q for the period revealed that Berkshire has been slow to deploy its growing pile of cash, perhaps contributing to the market’s muted response.